185 related articles for article (PubMed ID: 2880603)
1. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
[TBL] [Abstract][Full Text] [Related]
2. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease.
Silke B; Verma SP; Sharma SK; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1989 Jan; 13(1):155-61. PubMed ID: 2468927
[TBL] [Abstract][Full Text] [Related]
4. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
Taverner D; Mackay IG; Craig K; Watson ML
Br J Clin Pharmacol; 1991 Sep; 32(3):387-91. PubMed ID: 1685667
[TBL] [Abstract][Full Text] [Related]
5. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.
Dahlöf B; Danielson M; Andersson O; Thulin T; Ohman P; Mörlin C; Boberg J; Karlberg BE; Jern S; Hansson L
Br J Clin Pharmacol; 1984 Dec; 18(6):831-6. PubMed ID: 6152175
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
Lund-Johansen P
Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
[TBL] [Abstract][Full Text] [Related]
8. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
Svendsen TL
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
[TBL] [Abstract][Full Text] [Related]
9. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
Majid PA; Schreuder JE; de Feyter PJ; Roos JP
J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
11. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
[TBL] [Abstract][Full Text] [Related]
12. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the relative safety of the beta-blockers ICI 141,292 and atenolol in patients with bronchial asthma.
Groth S; Tønnesen P; Asted M; Dirksen H; Sørensen PG
Eur J Clin Pharmacol; 1986; 30(6):653-8. PubMed ID: 3533563
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
16. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
[TBL] [Abstract][Full Text] [Related]
17. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
Daul A; Johnston T; Reher M; Krüger M; Brodde OE
J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
[TBL] [Abstract][Full Text] [Related]
18. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
Boberg J; Larsen FF; Pehrsson SK
Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
[TBL] [Abstract][Full Text] [Related]
19. The selectivity of xamoterol, prenalterol, and salbutamol as assessed by their effects in the presence and absence of ICI 118,551.
McCaffrey PM; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1988 May; 11(5):543-51. PubMed ID: 2455840
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
